Ascend Wellness (OTCMKTS:AAWH) & Synaptogenix (NASDAQ:TAOX) Financial Comparison

Ascend Wellness (OTCMKTS:AAWH) and Synaptogenix (NASDAQ:TAOX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Volatility and Risk

Ascend Wellness has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Synaptogenix has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Ascend Wellness and Synaptogenix, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascend Wellness	0	1	0	0	2.00
Synaptogenix	1	0	0	0	1.00

Earnings & Valuation

This table compares Ascend Wellness and Synaptogenix”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascend Wellness	$500.58 million	0.16	-$118.19 million	($0.57)	-0.70
Synaptogenix	$772,499.00	26.45	-$28.74 million	($3.85)	-0.66

Synaptogenix has lower revenue, but higher earnings than Ascend Wellness. Ascend Wellness is trading at a lower price-to-earnings ratio than Synaptogenix, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

17.3% of Ascend Wellness shares are owned by institutional investors. Comparatively, 10.3% of Synaptogenix shares are owned by institutional investors. 21.9% of Ascend Wellness shares are owned by company insiders. Comparatively, 2.7% of Synaptogenix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Ascend Wellness and Synaptogenix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ascend Wellness	-23.31%	N/A	-10.85%
Synaptogenix	-2,153.97%	-128.51%	-97.54%

Summary

Ascend Wellness beats Synaptogenix on 8 of the 12 factors compared between the two stocks.

About Ascend Wellness

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.

About Synaptogenix

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer’s disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.